1 completed, 1 recruiting. .
Follow Paolo Corradini: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Italian Observational Study on CAR-T Therapy for Lymphoma Diffuse Low Grade B-Cell Lymphoma, Primary Mediastinal Large B-cell Lymphoma (PMBCL) | Recruiting | Paolo Corradini | 5300 | 2019-10-30 | 2024-04-01 | |
| Immunologic Response After Pandemic Influenza A (H1N1) Vaccine in Onco- Hematologic Patients Reassortant vaccine virus NYMC X-179A (New York Medical College, New York) derived form the A/california/7/2009 (H1N1) virus - Lymphoma, Multiple Myeloma | Completed | Paolo Corradini | 124 | 2009-10-01 | 2024-01-09 |
Lymphoma (2) · Lymphoma, Follicular (1) · Lymphoma, Mantle-Cell (1) · Multiple Myeloma (1) · Myeloproliferative Disorders (1)
Italy (2)
PMID 26205583, PMID 26659572, PMID 26738796, PMID 28291388, PMID 28701367, PMID 28774879, PMID 29226797, PMID 29713087, PMID 30165206, PMID 30275569, PMID 30518502, PMID 30592986, PMID 30782611, PMID 31201248, PMID 32242358, PMID 32702097, PMID 32888407, PMID 33180899, PMID 34516954, PMID 34891224, PMID 35583610, PMID 36385707, PMID 36542826, PMID 36821768, PMID 37690811, PMID 39870308, PMID 40763273, PMID 41740850